Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06841913
PHASE4

Woodsmoke Exposure, Influenza Infection, and Nasal Immunity

Sponsor: University of North Carolina, Chapel Hill

View on ClinicalTrials.gov

Summary

This study will investigate the effects of woodsmoke (WS) exposure on human nasal mucosal immune responses to viral infection. The study tests the hypotheses that WS exposure modifies biomarkers of nasal mucosal immune function, increases in Live Attenuated Influenza Virus (LAIV) -induced nasal symptoms, and reduces mucosal antibody production.

Official title: The Effects of Woodsmoke Exposure on Nasal Immune Responses to Influenza Infection in Normal Human Volunteers

Key Details

Gender

All

Age Range

18 Years - 49 Years

Study Type

INTERVENTIONAL

Enrollment

112

Start Date

2025-09-26

Completion Date

2028-12-31

Last Updated

2026-04-30

Healthy Volunteers

Yes

Interventions

BIOLOGICAL

LAIV nasal vaccine is chosen as a model viral infection

Inoculation with LAIV

OTHER

Wood smoke

Wood smoke exposure concentrations at 500 ug/m3 for two hours.

BIOLOGICAL

Placebo for LAIV nasal vaccine is chosen as a model viral infection

Placebo for LAIV inoculation. Nasal administration of normal saline.

OTHER

Placebo for Wood Smoke (clean Air Exposure)

Clean Air Exposure for 2 hours

Locations (1)

Mary Ellen Jones

Chapel Hill, North Carolina, United States